48306 Federal Register / Vol. 80, No. 155 / Wednesday, August 12, 2015 / Notices 

Federal Register and posts on the 

Internet at www.nrsweb.org a notice of 

that revocation, along with the date by 

which States and local eligible 

providers must stop using the revoked 

test. 

Accessible Format: Individuals with 

disabilities can obtain this document in 

an accessible format (such as braille, 

large print, audiotape, or compact disc) 

on request to the contact person listed 

under FOR FURTHER INFORMATION

CONTACT in this notice. 

Electronic Access to This Document: 

The official version of this document is 

the document published in the Federal 

Register. Free Internet access to the 

official edition of the Federal Register 

and the Code of Federal Regulations is 

available via the Federal Digital System 

at: www.gpo.gov/fdsys. At this site you 

can view this document, as well as all 

other documents of this Department 

published in the Federal Register, in 

text or Adobe Portable Document 

Format (PDF). To use PDF you must 

have Adobe Acrobat Reader, which is 

available free at the site. 

You may also access documents of the 

Department published in the Federal 

Register by using the article search 

feature at: www.federalregister.gov. 

Specifically, through the advanced 

search feature at this site, you can limit 

your search to documents published by 

the Department. 

Program Authority: 20 U.S.C. 9212. 

Delegation of Authority: The Secretary of 

Education has delegated authority to Mark 

Mitsui, Deputy Assistant Secretary for 

Community Colleges for Career, Technical, 

and Adult Education to perform the 

functions and duties of the Acting Assistant 

Secretary for Career, Technical, and Adult 

Education. 

Dated: August 6, 2015. 

Mark Mitsui, 

Deputy Assistant Secretary for Community 

Colleges for Career, Technical, and Adult 

Education delegated the authority to perform 

the functions and duties of the Acting 

Assistant Secretary for Career, Technical, and 

Adult Education. 

[FR Doc. 2015–19847 Filed 8–11–15; 8:45 am] 

BILLING CODE 4000–01–P 

DEPARTMENT OF ENERGY 

Environmental Management SiteSpecific Advisory Board Chairs; Open 

Meeting 

AGENCY: Department of Energy. 

ACTION: Notice of open meeting. 

SUMMARY: This notice announces a 

meeting of the Environmental 

Management Site-Specific Advisory 

Board (EM SSAB) Chairs. The Federal 

Advisory Committee Act (Pub. L. 92– 

463, 86 Stat. 770) requires that public 

notice of this meeting be announced in 

the Federal Register. 

DATES: Wednesday, September 2, 2015

8:00 a.m.–5:00 p.m.; Thursday, 

September 3, 2015 8:00 a.m.–12:30 

p.m. 

ADDRESSES: La Fonda on the Plaza, 100 

East San Francisco Street, Santa Fe, NM 

87501. 

FOR FURTHER INFORMATION CONTACT: 

David Borak, Designated Federal 

Officer, U.S. Department of Energy, 

1000 Independence Avenue SW., 

Washington, DC 20585; Phone: (202) 

586–9928. 

SUPPLEMENTARY INFORMATION: Purpose of 

the Board: The purpose of the Board is 

to make recommendations to DOE–EM 

and site management in the areas of 

environmental restoration, waste 

management, and related activities. 

Tentative Agenda Topics: 

Wednesday, September 2, 2015 

Æ EM Program Update 

Æ Presentations: 

• Office of Acquisition and Project 

Management 

• Office of Site Restoration 

Æ EM SSAB Chairs’ Roundtable 

Discussions 

Æ Public Comment Period 

Thursday, September 3, 2015 

Æ Presentations: 

• Office of Waste Disposition 

• Office of External Affairs 

Æ EM SSAB Chairs’ Roundtable 

Discussions 

Æ Public Comment Period 

Public Participation: The EM SSAB 

Chairs welcome the attendance of the 

public at their advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Catherine 

Alexander at least seven days in 

advance of the meeting at the phone 

number listed above. Written statements 

may be filed either before or after the 

meeting with the Designated Federal 

Officer, David Borak, at the address or 

telephone listed above. Individuals who 

wish to make oral statements pertaining 

to agenda items should also contact 

David Borak. Requests must be received 

five days prior to the meeting and 

reasonable provision will be made to 

include the presentation in the agenda. 

The Designated Federal Officer is 

empowered to conduct the meeting in a 

fashion that will facilitate the orderly 

conduct of business. Individuals 

wishing to make public comment will 

be provided a maximum of five minutes 

to present their comments. 

Minutes: Minutes will be available by 

writing or calling David Borak at the 

address or phone number listed above. 

Minutes will also be available at the 

following Web site: http://energy.gov/

em/services/communicationengagement/em-site-specific-advisoryboard-em-ssab/chairs-meetings. 

Issued at Washington, DC on August 7, 

2015. 

LaTanya R. Butler, 

Deputy Committee Management Officer. 

[FR Doc. 2015–19809 Filed 8–11–15; 8:45 am] 

BILLING CODE 6450–01–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPP–2015–0423; FRL–9929–66] 

Nominations to the FIFRA Scientific 

Advisory Panel; Request for 

Comments 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: This notice provides the 

names, addresses, professional 

affiliations, and selected biographical 

data of persons recently nominated to 

serve on the Scientific Advisory Panel 

(SAP) established under section 25(d) of 

the Federal Insecticide, Fungicide, and 

Rodenticide Act (FIFRA). The Panel was 

created on November 28, 1975, and 

made a statutory Panel by amendment 

to FIFRA, dated October 25, 1988. The 

Agency, at this time, anticipates 

selecting two new members to serve on 

the panel as a result of membership 

terms that will expire in 2015. Public 

comments on the current nominations 

are invited, as these comments will be 

used to assist the Agency in selecting 

the new chartered Panel members. 

DATES: Comments, identified by docket 

ID number EPA–HQ–OPP–2015–0423, 

must be received on or before August 

27, 2015. 

ADDRESSES: Submit your comments, 

identified by docket identification (ID) 

number EPA–HQ–OPP–2015–0423, by 

one of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the online 

instructions for submitting comments. 

Do not submit electronically any 

information you consider to be 

Confidential Business Information (CBI) 

or other information whose disclosure is 

restricted by statute. 

• Mail: OPP Docket, Environmental 

Protection Agency Docket Center (EPA/ 

DC), (28221T), 1200 Pennsylvania Ave. 

NW., Washington, DC 20460–0001. 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 155 / Wednesday, August 12, 2015 / Notices 48307 

• Hand Delivery: To make special 

arrangements for hand delivery or 

delivery of boxed information, please 

follow the instructions at http://

www.epa.gov/dockets/contacts.html. 

FOR FURTHER INFORMATION CONTACT: 

Steven M. Knott, DFO, Office of Science 

Coordination and Policy (7201M), 

Environmental Protection Agency, 1200 

Pennsylvania Ave. NW., Washington, 

DC 20460–0001; telephone number: 

(202) 564–0103; fax number: (202) 564– 

8382; email address: knott.steven@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action is directed to the public 

in general. This action may, however, be 

of interest to persons who are or may be 

required to conduct testing of chemical 

substances under the Federal Food, 

Drug, and Cosmetic Act (FFDCA) and 

FIFRA. Since other entities may also be 

interested, the Agency has not 

attempted to describe all the specific 

entities that may be affected by this 

action. If you have any questions 

regarding the applicability of this action 

to a particular entity, consult the DFO 

listed under FOR FURTHER INFORMATION

CONTACT. 

B. What should I consider as I prepare 

my comments for EPA? 

When submitting comments, 

remember to: 

1. Identify the document by docket ID 

number and other identifying 

information (subject heading, Federal 

Register date and page number). 

2. Follow directions. The Agency may 

ask you to respond to specific questions 

or organize comments by referencing a 

Code of Federal Regulations (CFR) part 

or section number. 

3. Explain why you agree or disagree; 

suggest alternatives and substitute 

language for your requested changes. 

4. Describe any assumptions and 

provide any technical information and/ 

or data that you used. 

5. If you estimate potential costs or 

burdens, explain how you arrived at 

your estimate in sufficient detail to 

allow for it to be reproduced. 

6. Provide specific examples to 

illustrate your concerns and suggest 

alternatives. 

7. Explain your views as clearly as 

possible, avoiding the use of profanity 

or personal threats. 

8. Make sure to submit your 

comments by the comment period 

deadline identified. 

II. Background 

The FIFRA SAP serves as the primary 

scientific peer review mechanism of 

EPA’s Office of Chemical Safety and 

Pollution Prevention (OCSPP) and is 

structured to provide scientific advice, 

information and recommendations to 

the EPA Administrator on pesticides 

and pesticide-related issues as to the 

impact of regulatory actions on health 

and the environment. Established in 

1975 under FIFRA, the FIFRA SAP is a 

Federal advisory committee that 

operates in accordance with 

requirements of the Federal Advisory 

Committee Act (FACA). The FIFRA SAP 

is composed of a permanent panel 

consisting of seven members who are 

appointed by the EPA Administrator 

from nominees provided by the National 

Institutes of Health (NIH) and the 

National Science Foundation (NSF). 

FIFRA established a Science Review 

Board consisting of at least 60 scientists 

who are available to the SAP on an ad 

hoc basis to assist in reviews conducted 

by the FIFRA SAP. As a peer review 

mechanism, the FIFRA SAP provides 

comments, evaluations and 

recommendations to improve the 

effectiveness and quality of analyses 

made by Agency scientists. Members of 

the FIFRA SAP are scientists who have 

sufficient professional qualifications, 

including training and experience, to 

provide expert advice and 

recommendations to the Agency. 

In accordance with the statute, the 

SAP is composed of a permanent panel 

of seven members, selected and 

appointed by the Deputy Administrator 

of EPA, as designated by the 

Administrator from nominees submitted 

by both the NSF and the NIH. The 

Agency, at this time, anticipates 

selecting two new members to serve on 

the panel as a result of membership 

terms that will expire this year. The 

Agency requested nominations of 

experts to be selected from the fields of 

human toxicology, environmental 

toxicology, pathology, risk assessment 

and/or environmental biology with 

demonstrated experience and expertise 

in all phases of the risk assessment 

process including: Planning, scoping, 

and problem formulation; analysis; and 

interpretation and risk characterization 

(including the interpretation and 

communication of uncertainty). 

Nominees should be well published and 

current in their field of expertise. The 

statute further stipulates that we publish 

the name, address and professional 

affiliation in the Federal Register. 

III. Charter 

A Charter for the FIFRA Scientific 

Advisory Panel dated October 17, 2014 

was issued in accordance with the 

requirements of the Federal Advisory 

Committee Act, Public Law 92–463, 86 

Stat. 770 (5 U.S.C. App. I). 

A. Qualifications of Members 

Members are scientists who have 

sufficient professional qualifications, 

including training and experience, to 

provide expert comments on the impact 

of pesticides on health and the 

environment. No persons shall be 

ineligible to serve on the Panel by 

reason of their membership on any other 

advisory committee to a Federal 

department or agency or their 

employment by a Federal department or 

agency (except the EPA). The Deputy 

Administrator appoints individuals to 

serve on the Panel for staggered terms of 

3 years. Panel members are subject to 

the provisions of 40 CFR part 3, subpart 

F, Standards of Conduct for Special 

Government Employees, which include 

rules regarding conflicts of interest. 

Each nominee selected by the Deputy 

Administrator, before being formally 

appointed, is required to submit a 

confidential statement of employment 

and financial interests, which shall fully 

disclose, among other financial 

interests, the nominee’s sources of 

research support, if any. 

In accordance with section 25(d)(1) of 

FIFRA, the Deputy Administrator shall 

require all nominees to the Panel to 

furnish information concerning their 

professional qualifications, educational 

background, employment history, and 

scientific publications. 

B. Applicability of Existing Regulations 

With respect to the requirements of 

section 25(d) of FIFRA that the 

Administrator promulgate regulations 

regarding conflicts of interest, the 

Charter provides that EPA’s existing 

regulations applicable to Special 

Government Employees, which include 

advisory committee members, will 

apply to the members of the Scientific 

Advisory Panel. These regulations 

appear in 40 CFR part 3, subpart F. In 

addition, the Charter provides for open 

meetings with opportunities for public 

participation. 

C. Process of Obtaining Nominees 

In accordance with the provisions of 

section 25(d) of FIFRA, EPA, on April 

21, 2015, requested that the NIH and the 

NSF nominate scientists to fill vacancies 

occurring on the Panel. The Agency 

requested nominations of experts in the 

fields of human toxicology, 

environmental toxicology, pathology, 

mstockstill on DSK4VPTVN1PROD with NOTICES

48308 Federal Register / Vol. 80, No. 155 / Wednesday, August 12, 2015 / Notices 

risk assessment, and/or environmental 

biology with demonstrated experience 

and expertise in all phases of the risk 

assessment process including: Planning, 

scoping, and problem formulation; 

analysis; and interpretation and risk 

characterization (including the 

interpretation and communication of 

uncertainty). NIH and NSF responded 

by letter, providing the Agency with a 

total of 34 nominees. Copies of these 

letters, with the listed nominees, are 

available in the public docket 

referenced in unit I.B.1. of this notice. 

Of the 34 nominees, 18 are interested 

and available to actively participate in 

SAP meetings (see Section IV. 

Nominees). One nominee is currently 

serving as member of the FIFRA SAP, 

and is not listed. In addition to the 

current nominees interested, at EPA’s 

discretion, nominees who were 

interested and available during the 

previous nomination process in the 

January 24, 2014 Federal Register (79 

FR 4158) (FRL–9904–66), may also be 

considered. Of the current 34 

nominations, the following 15 

individuals are not available: 

1. Asa Bradman, Ph.D., University of CA, 

Berkeley, CA. 

2. Mark G. Evans, DVM, Ph.D., ACVP, 

Pfizer Global Research and Development 

Drug Safety Research and Development, San 

Diego, CA. 

3. John Groopman, Ph.D., Johns Hopkins 

University, Baltimore, MD. 

4. Stephen S. Hecht, Ph.D., University of 

Minnesota, Minneapolis, MN. 

5. Marie Lyn Miranda, Ph.D., Rice 

University, Houston, TX. 

6. Frederica P. Perera, Ph.D., MPH, 

Columbia University, New York, NY. 

7. Irva Hertz-Picciotto, Ph.D., University of 

California, Davis, CA. 

8. Thomas A.E. Platts-Mills, M.D., 

University of Virginia, Charlottesville, VA. 

9. Michael Roe, Ph.D., North Carolina State 

University, Raleigh, NC. 

10. Ana Diez Roux, M.D, Ph.D., MPH, 

Drexel University, Philadelphia, PA. 

11. Jonathan M. Samet, MD, University of 

Southern California, Los Angeles, CA. 

12. David Siegel, MD, National Institute of 

Health, Rockville, MD. 

13. Allan H. Smith, MD, Ph.D., University 

of California, Berkeley, CA. 

14. Frank Speizer, SCD, MD, Harvard 

Medical School, Boston, MA. 

15. Robert Williams, MD, University of 

New Mexico Health Sciences Center, 

Albuquerque, NM. 

IV. Nominees 

Following are the names, addresses, 

professional affiliations, and selected 

biographical data of current nominees 

being considered for membership on the 

FIFRA SAP. The Agency anticipates 

selecting two individuals to fill 

vacancies occurring in 2015. 

1. Nicole L. Achee, Ph.D. 

i. Expertise: Epidemiology control of 

arthropod-borne diseases including 

evaluation of vector ecology, habitat 

management, and adult control 

strategies, disease risk modeling using 

GIS and remote sensing technologies, 

and evaluation of chemical actions 

against mosquito vectors under both 

laboratory and field conditions. 

ii. Education: Ph.D. Medical 

Entomology, Uniformed Services 

University of the Health Sciences; MSc, 

Zoology, Texas A&M University; BS, 

Biology, St. Louis University. 

iii. Professional Experience: Dr. Achee 

is a Medical Entomologist (Research 

Associate Professor) within the 

Department of Biological Sciences and 

holds a joint Associate Professor 

appointment in the Eck Institute for 

Global Health at the University of Notre 

Dame. She joined the University of 

Notre Dame faculty in 2013, following a 

2-year position as Assistant Professor at 

the Uniformed Services University of 

the Health Sciences in Bethesda, MD. 

She has a combined 15 years of 

experience in vector behavior research 

related to the epidemiology and control 

of arthropod-borne diseases, including 

evaluation of vector ecology, habitat 

management and adult control 

strategies, disease risk modeling using 

GIS and remote sensing technologies, 

and evaluation of chemical actions 

against mosquito vectors under both 

laboratory and field conditions. She has 

worked in the international settings of 

Belize, Mexico, Peru, Suriname, 

Indonesia, Nepal, South Korea, 

Thailand, and Tanzania. Dr. Achee was 

the principal investigator of a research 

program funded by the Bill & Melinda 

Gates Foundation focused on the 

development of spatial repellents in 

combination push-pull systems to 

reduce human-vector contact for dengue 

prevention. She is a Working Group 

member of the World Health 

Organization (WHO) Pesticide 

Evaluation Scheme (WHOPES), the 

Chair of the American Committee of 

Medical Entomology (ACME) of the 

American Society of Tropical Medicine 

and Hygiene (ASTMH), a representative 

of the WHO Global Collaboration for the 

Development of Pesticides for Public 

Health partnership (GCDPP), Vector 

Control Working Group member of Roll 

Back Malaria and served as the lead 

scientist for the recent publication of the 

WHO Guidelines for Efficacy Testing of 

Spatial Repellents. She is currently the 

lead Principal Investigator of a 

multicenter intervention trial dedicated 

to generating evidence of the protective 

efficacy of spatial repellents for 

prevention of malaria and dengue 

human infections for use towards full 

WHO recommendations. Her latest 

efforts have been dedicated to coDirecting the Belize Vector and Ecology 

Center (BVEC) in Orange Walk Town, 

Belize to serve as a regional platform of 

excellence for research and education in 

arthropod-borne diseases. 

2. George B. Corcoran, Ph.D., ATS 

i. Expertise: Pharmacological and 

toxicological adverse cellular outcomes, 

and factors that govern drug and 

chemical injuries including drug 

metabolism and nutrition. 

ii: Education: Ph.D., Pharmacology, 

Department of Pharmacology, School of 

Medicine, George Washington 

University; MS, Chemistry, Bucknell 

University; BA, Chemistry, Ithaca 

College. 

iii. Professional Experience: Dr. 

Corcoran is Professor and Chairman of 

the Department of Pharmaceutical 

Sciences, College of Pharmacy & Health 

Sciences, Wayne State University, and 

Adjunct Professor of Pediatrics, Wayne 

State University School of Medicine. Dr. 

Corcoran earned his BA in Chemistry 

(Ithaca College ‘70), MS in Chemistry 

(Bucknell University ‘73), and Ph.D. in 

Pharmacology/Toxicology (George 

Washington University ‘80), before 

completing Postdoctoral Fellow training 

in Toxicology (Baylor College of 

Medicine and Methodist Hospital ‘81). 

Prior to his appointment at Wayne State, 

Dr. Corcoran served as Assistant 

Professor of Pharmaceutics at the State 

University of New York at Buffalo, 

followed by Associate Professor and 

later Professor, and Director of the 

Toxicology Graduate Program at the 

University of New Mexico. Dr. Corcoran 

has published over 200 original research 

papers, abstracts and other reports, and 

has received nearly $6 million in grants 

and contracts as Principal Investigator, 

Co-Principal Investigator, and CoInvestigator. He has chaired grant 

review panels for the NIH, the National 

Academies, and the Howard Hughes 

Medical Institute, and has refereed 

papers for more than 50 national and 

international scientific journals. He has 

contributed to the training of over 150 

MS and Ph.D. graduates, 3200 

pharmacists, and hundreds of 

undergraduate research students. His 

research interests are multidisciplinary 

and translational. They focus on cellular 

injury and cell death, and factors that 

govern drug and chemical injuries, 

including drug metabolism and 

nutrition. Approaches to translate basic 

discoveries to improve human health 

involve retrospective and prospective 

clinical investigation of human 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 155 / Wednesday, August 12, 2015 / Notices 48309 

volunteers and patients, integrated in 

vivo models, cellular and molecular 

biology, pharmacokinetics, and 

synthetic chemistry. Specific areas of 

investigation include cell death by 

necrosis and apoptosis, the role of DNA 

damage in acute cell death, drug and 

chemical injury to the liver, nutrition 

and particularly obesity as overlooked 

factors in drug and chemical injury, 

drug biotransformation including by 

CYPs, and toxicity of drugs such as 

acetaminophen (paracetamol). Dr. 

Corcoran is a Fellow of the Academy of 

Toxicological Sciences, the top US 

credentialing organization for 

toxicologists. He was elected to its 

Executive Board and appointed to the 

National Toxicology Program Board of 

Scientific Counselors in 2012. He has 

been a Delegate to the International 

Congress of Toxicology and member of 

the International Union of Toxicology 

Developing Countries Committee. He is 

a former Member of the Science 

Advisory Board of the US 

Environmental Protection Agency, is 

former Chair of the Executive Board of 

the Council of Scientific Society 

Presidents, and is a past member of the 

Intergovernmental Scientific Advisory 

Committee on Alternative Toxicological 

Methods. He has contributed to the 

scientific direction of the American 

Society for Pharmacology and 

Experimental Therapeutics as a member 

of its Scientific Council, and served on 

the Research and Graduate Affairs 

Committee of the American Association 

of Colleges of Pharmacy. Dr. Corcoran is 

sought as an expert in toxic tort, product 

liability and other legal matters. At the 

University of New Mexico, Dr. Corcoran 

advised Health Sciences Vice President 

Jane Henney (FDA Commissioner 1998– 

2000) as a member of her Health 

Sciences Leadership Council. He is Past 

President of the Society of Toxicology, 

the largest toxicology organization in 

the world with over 7,000 members 

from academia, industry, government, 

medicine, law and other fields 

practicing in the USA and over 50 

foreign countries. He has contributed to 

Society positions having national and 

international impact, from the best 

science for evidence-based safety 

legislation, to organization ethics and 

governance. He serves as Associate 

Editor of Toxicology and Applied 

Pharmacology [2002-date], Editor of the 

Journal of Pharmaceutical Sciences and 

Pharmacology [2014-date] and Editor of 

the MO Online Journal of Toxicology 

[2014-date]. He has been an Editorial 

Board Member of the international 

journals Pharmacology and Toxicology, 

Basic and Clinical Pharmacology and 

Toxicology, Toxicology Letters, and the 

Journal of Toxicology and 

Environmental Health. During his 

service on the National Institutes of 

Health Alcohol-Toxicology 1 Study 

Section, he evaluated over 1,000 NIH 

grant applications. 

3. Deborah A. Cory-Slechta, Ph.D. 

i. Expertise: Relationship between 

brain neurotransmitter systems and 

neurodevelopment associated with 

alteration by exposures to 

environmental toxicants. 

ii: Education: Ph.D., Experimental 

Psychology, University of Minnesota; 

MA, Experimental Psychology, Western 

Michigan University; BS, Psychology, 

Western Michigan University. 

iii. Professional Experience: Dr. 

Deborah Cory-Slechta is a Professor in 

the Department of Environmental 

Medicine, Pediatrics and Public Health 

Sciences at the University of Rochester 

School of Medicine and Dentistry. Dr. 

Deborah Cory-Slechta became Chair of 

its Department of Environmental 

Medicine and Director of the NIEHS 

Environmental Health Sciences Center 

in 1998, and served as Dean for 

Research from 2000–2002. She then 

became Director of the Environmental 

and Occupational Health Sciences 

Institute (EOHSI) and Chair of the 

Department of Environmental and 

Community Medicine at the UMDNJRobert Wood Johnson Medical School 

from 2003–2007, before returning to 

URMC as Professor in Environmental 

Medicine, Pediatrics and Public Health 

Sciences. Dr. Cory-Slechta has served on 

national review and advisory panels of 

the National Institutes of Health, the 

National Institute of Environmental 

Health Sciences, the Food and Drug 

Administration, the National Center for 

Toxicological Research, the 

Environmental Protection Agency, the 

National Academy of Sciences, the 

Institute of Medicine, and the Agency 

for Toxic Substances and Disease 

Registry, Centers for Disease Control. In 

addition, Dr. Cory-Slechta has served on 

the editorial boards of the journals 

Neurotoxicology, Toxicology, 

Toxicological Sciences, Fundamental 

and Applied Toxicology, 

Neurotoxicology and Teratology, and 

American Journal of Mental Retardation. 

She has held the elected positions of 

President of the Neurotoxicology 

Specialty Section of the Society of 

Toxicology, President of the Behavioral 

Toxicology Society, and been named a 

Fellow of the American Psychological 

Association. Her research has focused 

largely on the relationships between 

brain neurotransmitter systems and 

neurodevelopment, and how such 

relationships are altered by exposures to 

environmental toxicants, including the 

role played by environmental 

neurotoxicant exposures in 

developmental disabilities and 

neurodegenerative diseases. This work 

has included the effects of 

developmental exposures to metals, 

pesticides, and air pollutants as well as 

combined exposures to metals and 

stress in experimental animal models as 

well as in human cohort studies. These 

research efforts have resulted in over 

155 papers and book chapters to date. 

4. Victor G. De Gruttola, ScD 

i. Expertise: Development of 

innovative study designs and analytical 

methods for evaluation of new therapies 

for HIV-related disease. 

ii. Education: ScD, Biostatistics, 

Harvard School of Public Health; SM, 

Bioengineering, Harvard University; 

SM, Epidemiology, Harvard School of 

Public Health; BS, Physics, Brown 

University. 

iii. Professional Experience: Dr. De 

Gruttola received his ScD in 1986 from 

the Biostatistics Department at HSPH— 

the department for which he served as 

Chair from 2009–2014. His research 

focuses on development of statistical 

methods required for appropriate public 

health response to the AIDS epidemic 

both within the US and internationally. 

The aspects of the epidemic on which 

he has worked include transmission of, 

and natural history of infection with, 

the Human Immunodeficiency Virus 

(HIV), as well as research on 

antiretroviral treatments, including the 

development and consequences of 

resistance to treatments. The broad goals 

of his research include developing 

treatment strategies that provide durable 

virologic suppression while preserving 

treatment options after failure, and 

evaluating the community-level impact 

of packages of prevention interventions, 

including antiviral treatment. He served 

as the Director of the Statistics and Data 

Analysis Center of the Adult Project of 

the AIDS Clinical Trials Group from 

1996 to 2003—the period in which 

highly active antiretroviral treatment 

was developed, and he was 

instrumental in designing and analyzing 

studies of the best means of providing 

such therapy. He also served from 2011– 

2015, as co-PI (with PI Max Essex) on a 

community-randomized study of a 

combination HIV prevention strategy in 

Botswana. 

5. David C. Dorman, DVM, Ph.D., 

DABVT, DABT, ATS 

i. Expertise: Neurotoxicology, and risk 

assessment. 

mstockstill on DSK4VPTVN1PROD with NOTICES

48310 Federal Register / Vol. 80, No. 155 / Wednesday, August 12, 2015 / Notices 

ii: Education: Ph.D., Veterinary 

Biosciences/Toxicology, University of 

Illinois; DVM Colorado State University; 

B.A. Chemistry, University of San 

Diego. 

iii. Professional Experience: Dr. 

Dorman is a professor of toxicology in 

the Department of Molecular 

Biosciences in the College of Veterinary 

Medicine at North Carolina State 

University. Dr. Dorman received his 

undergraduate training in chemistry 

from the University of San Diego, his 

DVM from Colorado State University, 

and he completed a combined Ph.D. and 

residency program in toxicology at the 

University of Illinois, UrbanaChampaign. He is a diplomat of the 

American Board of Veterinary 

Toxicology and the American Board of 

Toxicology. Dr. Dorman has chaired or 

served on numerous NRC committees. 

His recent NRC chairmanships include 

the Committee on Predictive-Toxicology 

Approaches for Military Assessments of 

Acute Exposures and the Committee on 

Design and Evaluation of Safer 

Chemical Substitutions—A Framework 

to Inform Government and Industry 

Decisions. He has been recently named 

as chair of the NRC’s Committee on 

Toxicology and the Committee on 

Unraveling Low Dose Toxicity: Case 

Studies of Systematic Review of 

Evidence. He has served on other 

advisory boards for the US Navy, NASA, 

and USDA, and is currently a member 

of the National Toxicology Program’s 

Board of Scientific Counselors. He is an 

elected fellow of both the Academy of 

Toxicological Sciences and the 

American Association for the 

Advancement of Sciences. The primary 

objective of his research is to provide a 

refined understanding of chemically 

induced neurotoxicity in laboratory 

animals that will lead to improved 

assessment of potential neurotoxicity in 

humans. Dr. Dorman’s other research 

interests include clinical veterinary 

toxicology, nasal toxicology, 

pharmacokinetics, and cognition and 

olfaction in animals. He has over 145 

peer-reviewed research publications 

including work with pesticides, metals, 

hydrogen sulfide, and a variety of 

industrial chemicals. 

6. Valery E. Forbes, Ph.D. 

i. Expertise: Population ecology and 

modeling, fate and effects of toxic 

chemicals in sediments, and ecological 

risk assessment. 

ii. Education: Ph.D., Coastal 

Oceanography, State University of New 

York; MSc Marine Environmental 

Science, State University of New York; 

BA Biology; BA Geology, State 

University of New York. 

iii. Professional Experience: Dr. 

Valery E. Forbes is Dean of the College 

of Biological Sciences at University of 

Minnesota. Dr. Forbes was Director of 

the School of Biological Sciences at the 

University of Nebraska-Lincoln from 

2011–2015. From 1989–2010, she lived 

and worked in Denmark, most recently 

as the Founding Chair of the 

Department of Environmental, Social 

and Spatial Change and Professor of 

Aquatic Ecology and Ecotoxicology at 

Roskilde University. Dr. Forbes received 

her Bachelor’s Degree (Biology & 

Geology) from the State University of 

New York at Binghamton in 1983, a 

MSc (Marine Environmental Science) 

from SUNY-Stony Brook in 1984, and a 

Ph.D. (Coastal Oceanography), also from 

SUNY- Stony Brook in 1988. Specific 

research topics include population 

ecology and modeling, fate and effects 

of toxic chemicals in sediments, and 

ecological risk assessment. Dr. Forbes 

has graduated approximately 50 MSc 

and Ph.D. students over her career and 

established a Danish Graduate School in 

Environmental Stress Studies (GESS) 

based at Roskilde University. While 

based in Europe, Dr. Forbes served as 

work package leader on two major EU 

7th Framework Projects: CREAM (a 

Marie Curie Initial Training Network on 

Mechanistic Effect Models for 

Ecological Risk Assessment of 

Chemicals) and NanoReTox (a multiinstitution research project on The 

Reactivity and Toxicity of Engineered 

Nanoparticles: Risks to the Environment 

and Human Health). More recently, she 

has received funding from the National 

Institute of Mathematical and Biological 

Synthesis (NIMBioS) for multi-partite 

initiatives to develop predictive models 

for the ecological risk assessment of 

chemicals. Dr. Forbes has published 

well over 100 internationally peerreviewed articles and two books on 

these topics. She has served on the 

Danish Natural Sciences Research 

Council, the European Research Council 

and as ad hoc reviewer for numerous 

funding agencies from various 

countries. She is on the editorial board 

of several international journals and 

provides scientific advice to the private 

and public sectors. 

7. John Grieco, Ph.D. 

i. Expertise: Epidemiology, ecology, 

and transmission dynamics of vectorborne illness. 

ii. Education: Ph.D., Medical Zoology, 

Uniformed Services University; MS 

Medical Entomology, Texas A&M 

University; BS, Biology, University of 

Notre Dame. 

iii. Professional Experience: Dr. John 

Grieco is a Research Associate Professor 

of Medical Entomology and Associate 

Director of the Eck Institute of Global 

Health at the University of Notre Dame 

in Notre Dame, Indiana. Dr. Grieco’s 

work is multidisciplinary with a focus 

on the biology, ecology and 

transmission dynamics of vector-borne 

illness. He has a long history of working 

on vector borne disease throughout the 

tropics and his research centers on 

malaria, Japanese Encephalitis, Dengue, 

Chagas, and rickettsial pathogens. Dr. 

Grieco has an extensive history in the 

design of novel repellents, irritants and 

toxicants for disease vectors. He has 

developed a number of field and 

laboratory assays for identifying and 

optimizing behavior modifying 

compounds for use in the control of 

mosquito, sandfly, and triatome vectors. 

Dr. Grieco serves as an external advisor 

to the Bill and Melinda Gates 

Foundation, the World Health 

Organization (WHO), the US Centers for 

Disease Control and the US Department 

of Defense in the area of Spatial 

Repellents and their advancement to 

recommendation. Dr. Grieco has coauthored the WHO guidelines for the 

evaluation of spatial repellents and he 

currently holds two patents for novel 

repellent compounds. 

8. Byron Jones, Ph.D. 

i. Expertise: Toxicogenetics, 

neurobehavioral, and developmental 

toxicology. 

ii. Education: BA, Psychology, Eastern 

Washington University; MA, 

Psychology, University of Arizona; 

Ph.D. Physiological and Comparative 

Psychology, Psychopharmacology, 

University of Arizona. 

iii. Professional Experience: Dr. Byron 

Jones is professor of Genetics, 

Genomics, and Informatics at the 

University of Tennessee Health Sciences 

Center, Memphis. Dr. Jones received his 

Ph.D. training in the Departments of 

Psychology and Pharmacology and 

Toxicology at the University of Arizona. 

He received postdoctoral training in 

neuropharmacology at the University of 

Arizona and in pharmacogenetics at the 

University of Colorado. In 1991, he was 

a founding member of the Department of 

Biobehavioral Health at The 

Pennsylvania State University and 

developed a program in 

pharmacogenetics and toxicogenetics at 

that institution. He has trained 10 Ph.D. 

and 8 MS students and supervised 

numerous undergraduate honors theses 

at PSU. In 1998–1999, he was awarded 

a Poste Orange senior visiting research 

position at Institute Franc ̧ois Magendie, 

Bordeaux, France to study the genetics 

of alcohol consumption. In 2000, he was 

awarded a Harry Dozor visiting 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 155 / Wednesday, August 12, 2015 / Notices 48311 

professorship at the Ben Gurion 

University of the Negev, Beersheba, 

Israel. In 2001 and again in 2004, he was 

awarded invited professorships at the 

University of Strasbourg and University 

of Bordeaux in France. Together with 

his colleague, Dr. Pierre Morme`de and 

others, he has helped to organize and 

deliver 15 1–2 week workshops on 

neural and behavioral genetics in 

France, the USA, Brazil, Russia, and 

Sweden. He and Dr. Morme`de co-edited 

two volumes of a book on neuro and 

behavioral genetics. Dr. Jones has 

published more than 130 papers in peerreviewed journals. In 2013, Dr. Jones 

was invited to help develop research 

infrastructure to study the effects of 

mercury and pesticide exposure on 

neurocognitive development in 

Ecuador. In 2014, he was awarded two 

grants from the National Institutes of 

Health. One is focused on the role of 

genetics in the impact of chronic stress 

on neuroendocrine adaptation and 

alcohol consumption and the other to 

study the effects of genetics on paraquat 

neurotoxicity. In that year, he was 

recruited to help found a new 

department in Genetics, Genomics, and 

Informatics in the College of Medicine 

at UTHSC. He has served on several NIH 

and NSF review panels. He is on the 

editorial board of Frontiers in Genetics 

and Pharmacology, Biochemistry and 

Behavior and is Editor-in-Chief, 

Nutritional Neuroscience. His current 

research interests include: (1) The 

toxicogenetics of paraquat and other 

pesticides; (2) the impact of chronic 

stress on neurobehavioral adaptation, 

including alcohol consumption; (3) the 

role of iron status on accumulation of 

heavy metals; and (4) iron status and the 

exposure in pregnant women and in 

early childhood development. 

9. Paul D. Juarez, Ph.D. 

i. Expertise: Development of 

methodologies for creating and 

analyzing data on the effects of the 

natural, built, social, and policy 

environments on health disparities. 

ii. Education: Ph.D., Public Policy and 

Social Research, Brandeis University, 

Waltham; MEd Psychology, Western 

Washington University; BA, Western 

Washington University. 

iii. Professional Experience: Dr. Paul 

D. Juarez is Professor, Preventive 

Medicine and founding co-director of 

the Research Center on Health 

Disparities, Equity, and the Exposome at 

the University of Tennessee Health 

Science Center. He received his Ph.D. in 

social policy from the Heller School, 

Brandeis University in 1983. Dr. Juarez 

currently is serving appointments on the 

Federal Advisory Committee on 

Minority Health for the US Department 

of Health and Human Services (2014– 

2018) and the Community-Level Health 

Promotion Study Section, Center for 

Scientific Review of the NIH (2013– 

2016). Dr. Juarez previously served as 

the Vice Chair, Division of Community 

Health, Family & Community Medicine, 

Meharry Medical College. While at 

Meharry, Dr. Juarez was PI for the 

Meharry Health Disparities Research 

Center of Excellence and directed its 

community engagement core. As PI, Dr. 

Juarez led Center activities in 

developing a systems approach to health 

disparities research. In 2011, Dr. Juarez 

received a grant from the EPA to 

increase our understanding of the 

environmental context of health 

disparities. In pursuit of this effort, he 

led efforts to apply an exposome 

framework that considers the 

cumulative effects of environmental 

exposures on human health and 

development at critical life stages and 

from conception to death. He has been 

at the forefront nationally in developing 

a methodology for creating and 

analyzing data on the effects of the 

natural, built, social, and policy 

environments on health disparities. To 

achieve this, he has established a 

transdisciplinary team of investigators 

to conduct focused studies of the 

environmental effects on population 

level health disparities that apply 

mathematical, spatial-temporal, 

statistical and computational methods, 

models and analytics. His recent work 

has focused on analyzing the effects of 

the exposome on black white disparities 

in pre-term births and lung cancer 

mortality. 

10. Rebecca D. Klaper, Ph.D. 

i. Expertise: Ecological toxicology, 

chemical environment fate and effects, 

examining technologies (including 

genomics and green chemistry designs) 

to minimize environmental impacts 

from chemical contamination. 

ii. Education: BS, Honors Biology, 

University of Illinois; MS, Entomology, 

University of Georgia; Ph.D., Ecology, 

University of Georgia. 

iii. Professional Experience: Dr. 

Rebecca D. Klaper is a Professor at the 

School of Freshwater Sciences, 

University of Wisconsin-Milwaukee and 

the Director of the Great Lakes 

Genomics Center. Dr. Klaper received 

her MS in Entomology in 1995 and her 

Ph.D. in Ecology in 2000 from the 

Institute of Ecology University of 

Georgia examining the impacts of 

chemicals on the population dynamics 

of insects. Dr. Klaper currently studies 

the potential impact of emerging 

contaminants, such as nanoparticles, 

pharmaceuticals, personal care products 

and pesticides on aquatic life and how 

we may design these chemicals to be 

sustainable and have the least 

environmental impact. She published 

some of the first studies on the impacts 

of nanomaterials on aquatic organisms, 

describing differences in toxicity among 

nanomaterials, discussing the possible 

impacts of surfactants on nanomaterial 

toxicology. Dr. Klaper is now one of the 

lead PI’s for the Center for Sustainable 

Nanotechnology, a distributed Center of 

eight universities to evaluate the 

mechanisms by which nanomaterials 

may cause toxicity and investigate the 

potential for principles to use in the 

design process of these chemicals. Dr. 

Klaper received a AAAS-Science and 

Technology Policy Fellowship where 

she worked in the National Center for 

Environmental Assessment at the US 

Environmental Protection Agency 

evaluating the potential use of genomic 

technologies in risk assessment. She 

currently serves on the Board of 

Scientific Counselors for the US 

Environmental Protection Agency’s 

Chemical Safety for Sustainability/

Human Health Risk Assessment 

Subcommittee. She has served as a 

technical expert to the Alliance for the 

Great Lakes and the International Joint 

Commission regarding the potential 

impacts of pharmaceuticals, personal 

care products and other emerging 

contaminants on the Great Lakes. She 

has also served as an invited scientific 

expert to both the US National 

Nanotechnology Initiative and the 

International Organization for Economic 

Cooperation and Development panel on 

nanotechnology where she has testified 

on the potential impact of nanoparticles 

on the environment and the utility of 

current testing strategies. She served on 

the National Academy of Sciences Panel 

to Develop a Research Strategy for 

Environmental, Health, and Safety 

Aspects of Engineered Nanomaterials. 

She is also on the editorial board of the 

SETAC journal Environmental 

Toxicology and Chemistry as well as the 

ACS journal Chemical Research in 

Toxicology. Her current research 

focuses on (1) determining the presence 

of contaminants in freshwater systems; 

(2) the impacts of low level chronic 

exposures of these chemicals to fish and 

invertebrates in freshwater systems; (3) 

evaluating the ability of contaminant 

removal technologies to remove 

biological impacts of chemicals; (4) 

methods to quickly assess the potential 

impacts of a chemical, including 

genomic technologies; and (5) 

alternative options for minimizing the 

impacts of emerging contaminants 

mstockstill on DSK4VPTVN1PROD with NOTICES

48312 Federal Register / Vol. 80, No. 155 / Wednesday, August 12, 2015 / Notices 

including chemical redesign and Green 

Chemistry, altering use and distribution, 

and evaluating prescription levels for 

pharmaceuticals. Dr. Klaper’s goal is to 

conduct basic and applied research to 

inform policy decisions involving 

freshwater resources. 

11. Polly A. Newcomb, Ph.D. 

i. Expertise: Evaluating environmental 

exposures, such as metals, alcohol, 

tobacco, and medications, and lifestyle 

or physical factors, such as physical 

activity, body mass, genetics, and tumor 

characteristics. 

ii. Education: Ph.D., University of 

Washington, Seattle, Epidemiology; 

MPH, Epidemiology, University of 

Washington; BS, Molecular Biology, The 

Evergreen State College. 

iii. Professional Experience: Dr. Polly 

Newcomb is Head of the Cancer 

Prevention Program of the Public Health 

Sciences Division at the Fred 

Hutchinson Cancer Research Center 

(Fred Hutch), a Professor in the 

Department of Epidemiology at the 

University of Washington’s School of 

Public Health, and a Senior Scientist at 

the University of Wisconsin 

Comprehensive Cancer Center. She 

received her doctorate in Epidemiology 

at the University of Washington in 1986 

and completed her Post-doctoral 

Fellowship in the Department of Human 

Oncology at the University of Wisconsin 

in 1987. She has more than 25 years of 

extramurally funded research on cancer 

genetics, etiology, screening, and 

survival, demonstrating her broad 

expertise in the field. Her current 

research in relation to health and cancer 

includes environmental exposures such 

as metals, alcohol, tobacco, and 

medications; lifestyle factors, such as 

physical activity and body mass; as well 

as genetics and tumor characteristics. 

Her research has been funded by nearly 

a score of foundation and NIH-grants for 

these studies of colorectal neoplasia, 

breast and other cancers, and their 

precursors. She also participates in 

several international consortia. Dr. 

Newcomb has over 360 peer-reviewed 

publications, has served as a mentor for 

over 40 pre-doctoral, post-doctoral, and 

junior investigators and is on the 

Executive Committees of four University 

of Washington/Fred Hutch T32/R25 

training programs. She is active in 

training new researchers through a 

National Cancer Institute ‘‘Established 

Investigator’’ award focused on 

colorectal cancer survival. She has 

served as a member of numerous NIH 

Study Sections, a consultant to national 

and international organizations, and is 

an Editor/Associate Editor for top tier 

journals such as American Journal of 

Epidemiology and Cancer, 

Epidemiology, and Biomarkers & 

Prevention. She has recently been 

awarded mentoring awards from the 

University of Washington and the Fred 

Hutchinson Cancer Research Center, 

and is a Fulbright Scholar (2015). She is 

also the President of the American 

Society for Preventive Oncology. 

12. Melissa Perry, ScD, MHS 

i. Expertise: Epidemiologic research 

in public health. 

ii. Education: BA, Psychology, 

University of Vermont; MHS, Public 

Health, The Johns Hopkins University 

School of Hygiene and Public Health; 

ScD, Public Health, The Johns Hopkins 

University School of Hygiene and 

Public Health. 

iii. Professional Experience: Professor 

Melissa Perry is the elected President of 

the American College of Epidemiology. 

Dr. Melissa Perry received Master of 

Health Science and Doctor of Science 

degrees from the Johns Hopkins School 

of Hygiene and Public Health. She has 

spent more than two decades 

conducting epidemiologic research and 

educating over 50 graduate students in 

public health. Prior to coming to George 

Washington University in 2010, Dr. 

Perry spent 13 years on the Harvard 

School of Public Health’s Department of 

Environmental Health faculty. She is 

currently Chair on the Board of 

Scientific Counselors for the National 

Center for Environmental Health/

Agency for Toxic Substances and 

Disease Registry (NCEH/ATSDR) of the 

Centers for Disease Control and 

Prevention (CDC). She is also President 

of the American College of 

Epidemiology. She is an associate editor 

of the Journal Reproductive Toxicology, 

and she serves as a standing member of 

the National Institute for Occupational 

Safety and Health research grant study 

section. In 2014, Dr. Perry was elected 

to the prestigious international 

Collegium Ramazzini in recognition of 

her contributions to advancing 

occupational and environmental health 

and her professional integrity. From 

2009–2011, she was a member of the 

CDC’s Scientific Understanding Work 

Group, National Conversation on Public 

Health and Chemical Exposures, Centers 

for Disease Control and Prevention. 

From 2003–2007, she was a coinvestigator with the Tropical Pesticides 

Research Institute of Arusha, Tanzania, 

and the University of Cape Town, South 

Africa. Her laboratory at the Milken 

Institute School of Public Health focuses 

on reproductive epidemiology and 

hormone disruptors, and her group has 

developed new techniques for highvolume identification of chromosomal 

abnormalities in sperm cells. Her 

research group was the first to use semiautomated imaging methods to show 

how pesticides are associated with 

sperm abnormalities. In addition to 

numerous book chapters and published 

abstracts, she has over 110 peerreviewed publications in areas 

including DNA damage linked to 

pesticides and other chemical 

exposures, managing hazardous 

substances in the workplace, and 

occupational issues related to 

agricultural, meat-packing, and 

construction work. Current research on 

pesticides, biomarkers and hormonal 

effects in her laboratory focuses on 

identifying the mutagenic and hormonal 

effects of herbicide and insecticide 

exposure in vivo. Her interests focus on 

pre-disease exposure markers signaled 

by early mutational damage or hormone 

disruption, across the spectrum of 

pesticide exposure levels. She has been 

the principal investigator on research 

grants from the National Cancer 

Institute, the National Institute of 

Environmental Health Sciences, and the 

National Institute for Occupational 

Safety and Health. 

13. Patricia V. Pietrantonio, Ph.D., MS 

i. Expertise: Applied insect 

toxicology, insect endocrinology, and 

insect biochemistry and physiology. 

ii. Education: Ph.D., Entomology, 

University of California; MS, 

Entomology, Insect Toxicology track, 

University of California; BS Agronomy, 

Plant Breeding Track, University of 

Buenos Aires. 

iii. Professional Experience: Dr. 

Patricia Pietrantonio is a tenured 

Professor and AgriLife Research Fellow 

in the Department of Entomology at 

Texas A&M University in College 

Station, TX. She is an associate member 

of the interdisciplinary programs in 

Toxicology and a member of the Faculty 

of Neuroscience at the same university. 

She received her BS in Agronomy from 

the University of Buenos Aires in 

Argentina, after which she was a 

permanent technical staff member at 

INTA (National Institute of Agriculture 

and Cattle Technology) in Castelar, 

Buenos Aires (1982–1987). She obtained 

both her MS (1990) and Ph.D. (1995) in 

Entomology from the University of 

California at Riverside (both under Prof. 

Sarjeet S. Gill), with emphasis in insect 

toxicology, biochemistry, and 

physiology. As a Ph.D. student, she 

received the Henry Comstock Award 

from the Entomological Society of 

America (ESA) for outstanding graduate 

student achievement. Since 1996, she 

has advanced through the ranks at Texas 

A&M University, receiving the title of 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 155 / Wednesday, August 12, 2015 / Notices 48313 

‘‘AgriLife Research Fellow’’ for 

Outstanding Research Leadership and 

Grantsmanship in 2006. She has 

received funding from the NIH–NIAID 

(RO1), NIFA–AFRI, EPA Section 6 and 

the NSF–IOS, as well as from the Texas 

Department of Agriculture and USDASouthern Region IPM program. She has 

served three times as a member on 

national proposal review panels for 

USDA–NIFA Insects and Nematodes 

(organismal and sub-organismal panels) 

and twice for NSF–IOS panels. She 

reviews research proposals for European 

Organizations such as the FWO 

(Belgium), the ANR (French Natl. 

Agency), BBSRC from the UK, the DFG 

(German Research Foundation), and 

national universities. She has served 19 

years at Texas A&M University 

conducting entomological research 

ranging from applied insect toxicology 

to basic aspects insect endocrinology 

and insect biochemistry and physiology 

(G protein-coupled receptors: GPCRs) 

focusing on target validation. In applied 

toxicology her laboratory elucidated 

mechanisms of insecticide resistance to 

pyrethroids, neonicotinoids, and 

organophosphates in various pests such 

as mosquitoes, cotton bollworm (H. zea), 

boll weevil, and whiteflies. Some of this 

work was in collaboration with 

Extension Entomologists. She has 

conducted international research on 

insecticide resistance in Cyprus funded 

by the Cyprus Research Promotion 

Foundation. She has served as major 

professor of 7 Ph.D. students and 4 

masters students in her laboratory and 

served as committee member for 11 

graduate students (all completed). She 

has served as co-major professor or 

committee member for students enrolled 

in Universities in Mexico and Europe 

(UK Leuven, Belgium). Scholarly 

accomplishments include 49 published 

peer-reviewed journal articles, 7 book 

chapters, and 18 papers in conference 

proceedings, as well as published 

abstracts of 75 invited presentations (21 

international) and 116 volunteered 

presentations. She teaches yearly 

Graduate Courses in Insect Toxicology 

(ENTO619) and Insect Physiology 

(ENTO615). She has served as Subject 

Editor for ‘‘Environmental Entomology,’’ 

for which she received an Outstanding 

Service Award from the ESA. She is 

currently an associate editorial member 

in the Archives of Insect Biochemistry 

and Physiology and member of the 

Editorial board of Open Access Insect 

Physiology (Ed. Guy Smagghe). Other 

honors include the Paul A. Dahm 

Memorial Lecture in Insect Toxicology 

(Iowa State University) and the 2013 

College of Agriculture and Life Sciences 

Dean’s Outstanding Achievement 

Award for Faculty Mentoring. She was 

appointed to the University (TAMU) 

ADVANCE–NSF funded project as 

mentor for minority women. Current 

research funded by the NSF–IOS 

focuses on insect neurobiology and 

neuroendocrinology, and research 

funded by Cotton Incorporated focuses 

on Bt toxin and other receptors in the 

cotton bollworm, H. zea. Other projects 

focus on target validation in ticks. Dr. 

Pietrantonio is also a member of the tick 

genome Ix. scapularis expert group. 

14. Kenneth Ramos, MD, Ph.D., PharmB 

i. Expertise: Genomics and 

computational biology, molecular 

medicine, environmental health, and 

toxicology. 

ii. Education: BS, Pharmaceutical 

Sciences and Chemistry, University of 

Puerto Rico, Ph.D., Biochemical 

Pharmacology, The University of Texas; 

MD, University of Louisville Health 

Sciences Center. 

iii. Professional Experience: Kenneth 

Ramos, MD, Ph.D., PharmB, works 

across numerous organizational units at 

the University of Arizona (UA) to 

develop precision-health strategies and 

approaches to health outcomes and 

health-care delivery. He provides senior 

leadership in the development of 

personal diagnostics and therapeutics 

for complex diseases, including cancer, 

cardiopulmonary disorders, and 

diabetes. Dr. Ramos also is a professor 

of medicine at the UA College of 

Medicine–Tucson in the Department of 

Medicine, Division of Pulmonary, Sleep, 

and Critical Care Medicine, where he 

directs a highly competitive and 

innovative research program in 

translational and clinical genetics and 

genomics. Dr. Ramos’ research 

integrates approaches ranging from 

molecular genetics to population-based 

studies to understand the genomic basis 

of human disease. He is regarded as a 

leading expert in the study of geneenvironment interactions and directs a 

competitive research program in 

translational and clinical genomics with 

a focus on genetic and epigenetic 

determinants of toxicity and disease, 

computational biology and molecular 

signaling. Dr. Ramos has mentored over 

100 doctoral, medical, veterinary 

medicine, undergraduate and high 

school students, many of whom have 

gone on to successful careers in 

academia, medicine, government and 

industry. He is committed to initiatives 

that attract and retain minorities in 

science and medicine. Dr. Ramos served 

as SOT President from 2008–2009, and 

is a current member of the Continuing 

Medical Education Task Force, Hispanic 

Organization of Toxicologists Specialty 

Interest Group, and the Molecular and 

Systems Biology Specialty Section. He 

has been a member of SOT since 1982. 

15. Gary S. Sayler, Ph.D. 

i. Expertise: Microbial biodegradation, 

molecular microbiology, 

bioluminescence sensing and 

ecotoxicology. 

ii. Education: Ph.D., Bacteriology and 

Biochemistry, University of Idaho; BS, 

Bacteriology, North Dakota State 

University; AA, Liberal Arts, Bismarck 

Junior College. 

iii. Professional Experience: Dr. Sayler 

is Distinguished University Professor, 

and Alvin and Sally Beaman Endowed 

Professor of Microbiology and Ecology 

and Evolutionary Biology at The 

University of Tennessee. Dr. Sayler 

received his Ph.D. in Bacteriology and 

Biochemistry, University of Idaho, 1974; 

BS, Bacteriology, North Dakota State 

University, 1971; AA, Bismarck Junior 

College, Liberal Arts, 1969. He was 

Postdoctoral researcher in Marine 

Microbiology at the University of 

Maryland (1974–1975). He is the 

founding Director, Center for 

Environmental Biotechnology at the 

University of Tennessee (1986-present) 

and was the first Director of the UT– 

ORNL Joint Institute for Biological 

Sciences (2006–2014). As Director for 

the Waste Management Research and 

Education Institute Tennessee Center of 

Excellence (1991–2005) he conducted a 

consolidation and reorganization to 

create the Institute for a Secure and 

Sustainable Environment serving as 

interim director (2005–2006). 

Specializing in microbial 

biodegradation, molecular microbiology, 

bioluminescence sensing and 

ecotoxicology, he has directed the 

research of over 100 Ph.D. and MS 

students and postdocs during his 40 

year career, with approximately 400 

peer reviewed publications, 16 patents, 

and over 500 lectures and seminars 

worldwide. He serves on the Sciences 

Advisory Board for the US Defense 

Department, Strategic Environmental 

Research Defense Program (2011- 

present); and was a member of the US 

Department of Energy, Biological and 

Environmental Research Advisory 

Committee (2008–2013). He was an 

Executive member and Chair of the 

Board of Scientific Counselors for the 

EPA Office of Research and 

Development (2002–2010) and served 

on the EPA’s Science Advisory Board 

drinking water committee (2002–2009), 

the Water Environment Research 

Foundation Research Council (1995– 

2001) and was Peer Review Chair for the 

EPA Exploratory Biology Program 

mstockstill on DSK4VPTVN1PROD with NOTICES

48314 Federal Register / Vol. 80, No. 155 / Wednesday, August 12, 2015 / Notices 

(1990–1993). He has served on National 

Academy/NRC Committees evaluating 

the US EPA Laboratory Enterprise 

(2013–14), DOE NRSB-Environmental 

Management Roadmap (2007–2008) 

Stand-Off Explosives Detection (2003) 

and DOE Site Decontamination and 

Decommissioning (2002). He is Cofounder China-US Joint Research Center 

For Ecosystem and Environmental 

Change, Beijing, (2006-present) and US 

State Department Eco partnership (2010- 

present) and has held honorary 

Professorships at China Agricultural 

University, Beijing (2012), Northeast 

Normal University, Changchun (2012), 

East China University of Science and 

Technology, Shanghai (2008–2011), 

Institute for Water Research 

Distinguished Researcher, Xi’an (2008); 

and Adjunct Professorship, Gwanju 

Institute of Science and Technology, 

Korea (2005–2010). Dr. Sayler is an 

Associate Editor of Environmental 

Science and Technology and is an active 

member in ACS, AAAS, ASM and 

SETAC. Elected to AAAS Fellowship in 

2012. He received the DOW Foundation 

Support for Public Health 

Environmental Research and Education 

(SPHERE) Award (1998–2000); and was 

elected to the Fellow American 

Academy for Microbiology (1995- 

present). He received the Distinguished 

Alumni Award, University of Idaho and 

the UT Senior Researcher Award from 

the College of Arts and Sciences (1995) 

and received the Procter and Gamble 

Prize, American Society for 

Microbiology (1994). He was designated 

Chancellor’s Research Scholar, UTK 

(1988), and received the NIH Research 

Career Development Award (NIEHS), 

(1980–1985). 

16. Joseph Shaw, Ph.D. 

i. Expertise: Discovery of molecular 

toxicological and disease pathways 

resulting from complex environmental 

exposures including techniques in new 

high-throughput molecular techniques 

and evolutionary theory, statistical 

analysis, and bioinformatics. 

ii. Education: Ph.D., University of 

Kentucky; BS, Virginia Polytechnic 

Institute and State University. 

iii. Professional Experience: Dr. 

Joseph R. Shaw is an Associate 

Professor in the School of Public and 

Environmental Affairs at Indiana 

University and holds adjunct 

appointments in their School of Public 

Health and Center for Genomics and 

Bioinformatics. He also holds a partial 

appointment as a Senior Lecturer of 

Environmental Genomics in the School 

of Biosciences at the University of 

Birmingham, UK. Dr. Shaw earned his 

doctoral degree in environmental 

toxicology from the Graduate Center for 

Toxicology at the University of 

Kentucky in 2001. He then moved to 

Dartmouth College where he received an 

NIEHS post-doctoral fellowship to apply 

emerging Omics technologies to 

characterize mechanisms of toxicant 

actions. He joined the faculty of the 

School of Public and Environmental 

Affairs at Indiana University, 

Bloomington in 2007. Dr. Shaw was 

named an Outstanding New 

Environmental Scientist (ONES) by the 

NIEHS in 2010, and recognized as an 

exceptional talent in the environmental 

sciences by the Royal Society, UK in 

2013 for his work investigating toxicant 

exposure, genome structure, and toxic 

effects on individuals and populations. 

Contributing to these efforts he is a 

founding member of the Daphnia and 

Fundulus Genomics Consortia where he 

helps lead over 600 scientists around 

the world working to develop new 

models for environmental genomics. He 

also helped establish the Consortium for 

Environmental Omics and Toxicology 

that seeks to apply twenty-first century 

technologies to predictive toxicology. 

Dr. Shaw has trained over 150 students 

in environmental genomics through the 

Mount Desert Island Bio Lab Workshop 

in environmental genomics that he codeveloped in 2011. The workshop is 

now held annually in the US and UK. 

Dr. Shaw’s research program has 

received over $6.4M in research funding 

from NIH, NSF, and DOD since 2002, 

producing over 38 publications in the 

area of environmental genomics and 

toxicology. He has served on the 

editorial board and in 2013, was 

promoted to editor for the journal 

‘‘Environmental Toxicology and 

Chemistry.’’ His research group seeks to 

discover critical, specific, and causative 

molecular toxicological and disease 

pathways resulting from complex 

environmental exposures. His work 

embraces new high-throughput 

molecular techniques and couples these 

with evolutionary theory, statistical 

analysis, and bioinformatics to integrate 

toxic-response across levels of biological 

organization. Current research in his 

laboratory focuses on (i) associating 

variation in genome structure with 

disease and toxicant response within 

and between populations; (ii) 

identifying the mechanisms of actions of 

chemical stress, especially metals, and 

(iii) elucidating the genetic and 

epigenetic underpinnings of mutations 

and establishing their role in evolved 

tolerance. 

17. Sonya K. Sobrian, Ph.D. 

i. Expertise: Behavioral, 

immunological and neurotoxicological 

consequences of prenatal and neonatal 

drug administration and drug and 

environmental stress. 

ii. Education: Ph.D. Physiological 

Psychology, from Carleton University; 

BA and MA (Experimental) in 

Psychology from St. John’s University; 

MA equivalent in Pharmacology from 

Ottawa University. 

iii. Professional Experience: Dr. Sonya 

K. Sobrian is an Associate Professor of 

Pharmacology at the Howard University 

College of Medicine, Director of the 

Developmental Neurobehavioral 

Pharmacology Laboratory, and 

Immediate Past Chair of the University’s 

IACUC. Dr. Sobrian received her 

doctorate in Physiological Psychology 

from Carleton University, Ottawa 

Canada, and served a postdoctoral 

fellowship at Princeton University in 

Developmental Neurobiology; she also 

added pharmacology and immunology 

to her graduate (MA, 

Neuropharmacology: Ottawa University) 

and post graduate (Fulbright Fellow: 

Immunology Research Center, Belgrade, 

Yugoslavia) training. During her tenure 

at the College of Medicine, Dr. Sobrian 

successfully mentored medical, 

graduate, and undergraduate students. 

She has served as President of the 

Neurobehavioral Teratology Society, is 

currently on the Editorial Advisory 

Board of the journal, ‘‘Neurotoxicology 

and Teratology’’, and is Guest Editor of 

a special issue of the journal on 

‘‘Developmental Cannabinoid Exposure: 

New Perspectives on Mechanisms, 

Outcomes, and Implications for Public 

Health.’’ Dr. Sobrian is currently on the 

Board of Scientific Counselors for the 

Department of Health & Human Services 

National Toxicology Program. She also 

served as a member of the Scientific 

Advisory Panel for the US EPA Office of 

Chemical Safety and Pollution 

Prevention, and previously served on 

the EPA Toxic Substance Control Act 

Advisory Committee. As a visiting 

scientist at the National Center for 

Toxicological Research, Dr. Sobrian was 

instrumental in establishing a prenatal 

model of cocaine toxicity. She served on 

the ILSI Risk Science Institute’s Expert 

Panel on the evaluation and 

interpretation of neurodevelopmental 

endpoints for human risk. Dr. Sobrian 

served as Director of the Behavioral 

Neuroscience Program at the National 

Science Foundation, where she directed 

and managed funding of research on the 

neural mechanisms underlying behavior 

and learning. In addition, she has served 

as Chair of the Board of Trustees of 

AAALAC International, as well as Chair 

of the Board of Directors of the National 

Capital Area Chapter of the Fulbright 

Association. During her tenure as an 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 155 / Wednesday, August 12, 2015 / Notices 48315 

AAAS Congressional Science and 

Technology Fellow, her scientific 

expertise was utilized to inform public 

policy on Fetal Alcohol Syndrome, 

aging, and NIH research funding. The 

major focus of Dr. Sobrian’s research 

involves the behavioral, immunological, 

and neurotoxicological consequences of 

prenatal and neonatal drug 

administration and drug and 

environmental stress-induced 

alterations in behavioral and 

immunological development. She has a 

longstanding interest in sex differences, 

and her lab was the first to show that 

prenatal environmental and 

psychological stress differentially 

altered immune parameters in rat male 

and female offspring, research that she 

continued as a Fulbright Scholar at the 

Immunological Research Institute in 

Belgrade, Yugoslavia. Her current 

research involves the life-span 

consequences of prenatal exposure to 

cocaine and nicotine, alone and in 

combination, with an emphasis on drug 

addiction in the aging organism. In 

developing animal models for 

neuropsychiatric diseases, Dr. Sobrian is 

currently exploring the role of prenatal 

environmental noise stress [PENS] in 

the etiology of autism and depression. 

For her work in establishing an 

environmentally-mediated 

neurodevelopmental animal model of 

depression, Dr. Sobrian was designated 

a L. Vernon Maddox NARSAD 

investigator. 

18. Kristina Thayer, Ph.D. 

i. Expertise: Understanding the role of 

environmental exposures in diabetes 

and obesity, evaluating the predictive 

utility of high throughput screening 

data, and methods of exposure 

assessment. 

ii. Education: BS, Psychology, 

Pennsylvania State University; Ph.D., 

Biological Sciences, University of 

Missouri. 

iii. Professional Experience: Kristina 

Thayer, Ph.D. is Deputy Director of 

Analysis at the National Toxicology 

Program (NTP) and Director of the NTP 

Office of Health Assessment and 

Translation (OHAT) at the National 

Institute for Environmental Health 

Sciences (NIEHS) located on the campus 

of the National Institute for 

Environmental Health Sciences 

(NIEHS). OHAT conducts evaluations to 

assess the evidence that environmental 

chemicals, physical substances, or 

mixtures (collectively referred to as 

‘‘substances’’) may cause adverse health 

effects and provides opinions on 

whether these substances may be of 

concern given what is known about 

current human exposure levels. As 

Deputy Director of Analysis, she 

oversees OHAT and the NTP Office of 

the Report on Carcinogens. Before 

becoming director of OHAT, she held 

positions in the NTP Office of Liaison, 

Policy, and Review, the NIEHS Office of 

Risk Assessment Research and the NTP 

Center for the Evaluation of Risks to 

Human Reproduction (CERHR). Prior to 

joining the NTP/NIEHS, she was a 

senior scientist at the World Wildlife 

Fund and then at the Environmental 

Working Group. In addition to 

overseeing the development of OHAT 

and ORoC monographs, she has research 

interests in the areas of understanding 

the role of environmental exposures in 

diabetes and obesity, evaluating the 

predictive utility of high throughput 

screening data, and methods of 

exposure assessment. She is considered 

an expert on the application of 

systematic review methods to 

environmental health topics. 

Authority: 7 U.S.C. 136 et. seq.; 21 U.S.C. 

301 et seq. 

Dated: August 5, 2015. 

David Dix, 

Director, Office of Science Coordination and 

Policy. 

[FR Doc. 2015–19828 Filed 8–11–15; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPP–2015–0086; FRL–9931–20] 

Environmental Quality Issues and 

Pesticides Operations and 

Management State FIFRA Issues 

Research and Evaluation Group; 

Notice of Public Meeting 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: The Association of American 

Pesticide Control Officials (AAPCO)/

State FIFRA Issues Research and 

Evaluation Group (SFIREG), the 

Environmental Quality Issues (EQI) and 

the Pesticides Operations and 

Management (POM) committees will 

hold a joint 2-day meeting, beginning on 

September 21, 2015 and ending 

September 22, 2015. This notice 

announces the location and times for 

the meeting and sets forth the tentative 

agenda topics. 

DATES: The meeting will be held on 

Monday, September 21, 2015, from 8 

a.m. to 5 p.m. and 8:30 a.m. to 3 p.m. 

on Tuesday, September 22, 2015. 

To request accommodation of a 

disability, please contact the person 

listed in this notice under FOR FURTHER

INFORMATION CONTACT. Please contact 

EPA at least 10 days prior to the 

meeting, to give EPA as much time as 

possible to process your request. 

ADDRESSES: The meeting will be held at 

EPA, One Potomac Yard (South Bldg.) 

2777 Crystal Dr., Arlington, Virginia, 1st 

Floor, South Conference Room. 

FOR FURTHER INFORMATION CONTACT: Ron 

Kendall, Field and External Affairs 

Division (7506P), Office of Pesticide 

Programs, Environmental Protection 

Agency, 1200 Pennsylvania Ave. NW., 

Washington, DC 20460–0001; telephone 

number: (703) 305–5561; fax number: 

(703) 305–5884; email address: 

kendall.ron@epa.gov or Amy Bamber, 

SFIREG Executive Secretary, at aapcosfireg@comcast.net. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

You may be potentially affected by 

this action if you are interested in 

pesticide regulation issues affecting 

states and any discussion between EPA 

and SFIREG on field implementation 

issues related to human health, 

environmental exposure to pesticides, 

and insight into EPA’s decision-making 

process. You are invited and encouraged 

to attend the meetings and participate as 

appropriate. Potentially affected entities 

may include (but are not limited to) 

persons who are or may be required to 

conduct testing of chemical substances 

under the Federal Food, Drug and 

Cosmetics Act (FFDCA), or the Federal 

Insecticide, Fungicide, and Rodenticide 

Act (FIFRA) and those who sell, 

distribute or use pesticides, as well as 

any non-government organization. If 

you have any questions regarding the 

applicability of this action to a 

particular entity, please consult the 

person in this notice listed under FOR

FURTHER INFORMATION CONTACT. 

B. How can I get copies of this document 

and other related information? 

The docket for this action, identified 

by docket identification (ID) number 

EPA–HQ–OPP–2015–0086, is available 

at http://www.regulations.gov or at the 

Office of Pesticide Programs Regulatory 

Public Docket (OPP Docket) in the 

Environmental Protection Agency 

Docket Center (EPA/DC), West William 

Jefferson Clinton Bldg., Rm. 3334, 1301 

Constitution Ave. NW., Washington, DC 

20460–0001. The Public Reading Room 

is open from 8:30 a.m. to 4:30 p.m., 

Monday through Friday, excluding legal 

holidays. The telephone number for the 

Public Reading Room is (202) 566–1744 

and the telephone number for the OPP 

Docket is (703) 305–5805. Please review 

mstockstill on DSK4VPTVN1PROD with NOTICES